Literature DB >> 4989538

Comparison of cephalexin, penicillin V, and ampicillin in streptococcal infections in monkeys.

S Saslaw, H N Carlisle.   

Abstract

Intravenous inoculation of a group A hemolytic streptococcus caused lethal infections in all of 11 untreated monkeys. Daily intragastric administration of either 25 or 50 mg per kg per day, given in two equal morning and afternoon doses, yielded similar results in monkeys treated with cephalexin, penicillin V, and ampicillin; all eight monkeys in each therapy group survived. At dose levels of 12.5 mg per kg per day, six of eight, four of eight, and one of eight receiving cephalexin, penicillin V, and ampicillin, respectively, died. The differences observed at the lower dose level between cephalexin and ampicillin could be attributed, in part, to differences in the minimal inhibitory concentrations (MIC) of cephalexin (MIC = 0.24 mug/ml) and ampicillin (MIC = 0.01 mug/ml). The differences in results between penicillin V, which had the same MIC as ampicillin, could perhaps be attributed, in part, to shorter duration of antibacterial activity and higher protein binding of penicillin V. These studies support previous observations that cephalexin at 25 to 50 mg/kg doses is effective in severe streptococcal sepsis in monkeys.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4989538      PMCID: PMC376830          DOI: 10.1128/am.19.6.943-949.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  Oxacillin: laboratory and clinical evaluation.

Authors:  W M KIRBY; L S ROSENFELD; J BRODIE
Journal:  JAMA       Date:  1962-09-01       Impact factor: 56.272

2.  Further studies of streptococcal infection in normal and splenectomized monkeys.

Authors:  S Saslaw; H N Carlisle; M A Marietti
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

3.  The binding of antibiotics to serum proteins.

Authors:  G N Rolinson; R Sutherland
Journal:  Br J Pharmacol Chemother       Date:  1965-12

4.  Studies on therapy of staphylococcal infections in monkeys. 3. Comparison of cephalothin, cephaloridine and cephalexin.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1968-09       Impact factor: 2.378

5.  Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1969-06       Impact factor: 2.378

6.  Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine.

Authors:  R L Perkins; H N Carlisle; S Saslaw
Journal:  Am J Med Sci       Date:  1968-08       Impact factor: 2.378

7.  Studies on therapy of staphylococcal infections in monkeys. V. Comparison of cephalexin, oxacillin, cloxacillin, dicloxacillin and nafcillin.

Authors:  S Saslaw; H N Carlisle; J Sparks
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

8.  Cephalexin, a new orally absorbed cephalosporin antibiotic.

Authors:  W E Wick
Journal:  Appl Microbiol       Date:  1967-07
  8 in total
  4 in total

Review 1.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Comparison of clindamycin, erythromycin, and methicillin in streptococcal infections in monkeys.

Authors:  H N Carlisle; S Saslaw
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

3.  Effect of vincristine sulfate on Pseudomonas infections in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

4.  Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin.

Authors:  H N Carlisle; S Saslaw
Journal:  Appl Microbiol       Date:  1971-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.